arrow
C

Christine S. Falk

German Center for Lung Research
H指数:61
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes and treatment of early detectable donor-specific antihuman leukocyte antigen antibodies after lung transplantation: Insights from a 12-year experience

早期可检测到的供者特异性抗人白细胞抗原抗体在肺移植后的结局与治疗:基于12年经验的见解

2026-07-160
OAAI
Serotonin 5-HT7 receptor signaling modulates inflammatory responses and survival after myocardial infarction

5-HT7受体信号调节心肌梗死后炎症反应和存活

2026-06-170
OA
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer

肺癌中细胞毒性CD39<sup>+</sup>肿瘤相关NK细胞对NKG2A阻断的反应

2026-06-050
PRE
An in-depth analysis of the molecular changes induced by short-term calorie restriction before living kidney donation

短期热量限制对活体肾捐献前诱导的分子变化的深入分析

2026-05-280
OAAI
The pleuroparenchymal fibroelastosis atlas reveals aberrant cell states and their zonation as an alternate roadmap to lung fibrosis

胸膜实质纤维弹力组织增生图谱揭示了异常细胞状态及其分区,作为肺纤维化的替代路线图

2026-05-080
OA
Post-Acute Sequelae Patients with Severe COVID-19 History Show a Prolonged Inflammatory, Vascular Injury Pattern

重症COVID-19病史患者出现急性期后后遗症,表现出持续性的炎症和血管损伤模式

2026-04-010
PRE
Differentiation-induced reduction in functional diversity restricts the ability of cytomegalovirus-specific CD8 T cells to eliminate virus-infected cells

分化诱导的功能多样性降低限制了巨细胞病毒特异性CD8 T细胞清除病毒感染细胞的能力

2026-01-050
OAAI
Ex-vivo limb perfusion in military and civilian medicine: inspired by ex-vivo organ perfusion, pioneered for traumatic limb amputation and peripheral nerve regeneration

军事和民用医学中的离体肢体灌注: 受离体器官灌注的启发,率先用于创伤性肢体截肢和周围神经再生

2025-10-300
OAAI
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D☆

布勒韦尔肽的治疗反应与慢性丁型肝炎患者门静脉高压的改善相关。

2025-10-170
OAAI
From Model to Man: Understanding Tregs' Dual Role in MASLD

从模型到人类:理解Tregs在MASLD中的双重作用

2025-10-090
OAAI
Molecular signatures discriminating different types of rejection in human liver transplants

分子特征区分人类肝移植不同类型的排斥反应

2025-07-140
OAAI
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation

细菌和真菌微生物群在终末期肝硬化的不同集群与抗生素治疗、肠屏障功能障碍和系统性炎症相关。

2025-04-210
OA
Plasma immune signatures can predict rejection-free survival in the first year after pediatric liver transplantation
2024-11-010
OA